BEFORE AND AFTER

Pictures are always worth a thousand words.  Our physicians provide experienced, trustworthy care that is carefully tailored to our patient’s needs. We invite you to schedule a consult to explore the best preventative and restorative options for your skin.

botox®

BEFORE
BEFORE
AFTER (DAY 7)
AFTER (DAY 7)
BEFORE
BEFORE
AFTER (DAY 7)
AFTER (DAY 7)

Photos taken at full smile before and after treatment with BOTOXR® Cosmetic (onabotulinumtoxinA) at day 7. In two clinical studies, 26.1% and 20.3% of people had ≥ 2-grade improvement at day 30. In one of these studies, 67.9% of people had mild or no crow’s feet at day 30 after treatment.

Photos taken at full smile before and after treatment with BOTOXR® Cosmetic (onabotulinumtoxinA) at day 7. In two clinical studies, 26.1% and 20.3% of people had ≥ 2-grade improvement at day 30. In one of these studies, 67.9% of people had mild or no crow’s feet at day 30 after treatment.

BEFORE
BEFORE
AFTER (DAY 7)
AFTER (DAY 7)
BEFORE
BEFORE
AFTER (DAY 7)
AFTER (DAY 7)

Photos taken at full smile before and after treatment with BOTOXR® Cosmetic (onabotulinumtoxinA) at day 7. In two clinical studies, 26.1% and 20.3% of people had ≥ 2-grade improvement at day 30. In one of these studies, 67.9% of people had mild or no crow’s feet at day 30 after treatment.

Photos taken at maximum frown before and after treatment with BOTOXR® Cosmetic (onabotulinumtoxinA) at day 7. In clinical studies, physicians assessed 80% of people had significant improvement at day 30.

BEFORE
BEFORE
AFTER (DAY 7)
AFTER (DAY 7)
BEFORE
BEFORE
AFTER (DAY 7)
AFTER (DAY 7)

Photos taken at full smile before and after treatment with BOTOXR® Cosmetic (onabotulinumtoxinA) at day 7. In two clinical studies, 26.1% and 20.3% of people had ≥ 2-grade improvement at day 30. In one of these studies, 67.9% of people had mild or no crow’s feet at day 30 after treatment.

Photos taken at maximum frown before and after treatment with BOTOXR® Cosmetic (onabotulinumtoxinA) at day 7. In clinical studies, physicians assessed 80% of people had significant improvement at day 30.

BEFORE
BEFORE
AFTER (DAY 7)
AFTER (DAY 7)
BEFORE
BEFORE
AFTER (DAY 7)
AFTER (DAY 7)

Photos taken at full smile before and after treatment with BOTOXR® Cosmetic (onabotulinumtoxinA) at day 7. In two clinical studies, 26.1% and 20.3% of people had ≥ 2-grade improvement at day 30. In one of these studies, 67.9% of people had mild or no crow’s feet at day 30 after treatment.

Photos taken at maximum frown before and after treatment with BOTOXR® Cosmetic (onabotulinumtoxinA) at day 7. In clinical studies, physicians assessed 80% of people had significant improvement at day 30.

Botox WARNING: DISTANT SPREAD OF TOXIN EFFECT

Postmarketing reports indicate that the effects of BOTOX® Cosmetic and all botulinum toxin products may spread from the area of injection to produce symptoms consistent with botulinum toxin effects. These may include asthenia, generalized muscle weakness, diplopia, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence and breathing difficulties. These symptoms have been reported hours to weeks after injection. Swallowing and breathing difficulties can be life threatening and there have been reports of death. The risk of symptoms is probably greatest in children treated for spasticity but symptoms can also occur in adults treated for spasticity and other conditions, particularly in those patients who have an underlying condition that would predispose them to these symptoms. In unapproved uses, including spasticity in children, and in approved indications, cases of spread of effect have been reported at doses comparable to those used to treat cervical dystonia and upper limb spasticity and at lower doses.

Dermal fillers

Juvaderm XC® & Juvaderm XC Ultra Plus®

BEFORE
BEFORE
AFTER (2 WEEKS)
AFTER (2 WEEKS)
BEFORE
BEFORE
AFTER (2 WEEKS)
AFTER (2 WEEKS)

Model was treated for parentheses lines (JUVEDERM® Ultra, 0.5 mL; JUVEDERM® Ultra Plus, 1.5 mL), marionette lines (JUVEDERM® Ultra, 0.3 mL; JUVEDERM® Ultra Plus, 0.5 mL), and corner lines (JUVEDERM® ltra, 0.2 mL; JUVEDERM® Ultra Plus, 0.2 mL).

Model was treated for marionette lines (JUVEDERM® Ultra, 1.05 mL; JUVEDERM® Ultra Plus, 1.35 mL0, parentheses lines (JUVEDERM® Ultra, 0.8 mL; JUVEDERM® Ultra Plus, 0.3 mL), corner lines (JUVEDERM® Ultra, 0.25 mL; JUVEDERM® Ultra Plus, 0.25 mL), and vertical lip lines (JUVEDERM® Ultra, 0.1 mL; JUVEDERM® Ultra Plus, 0.1 mL).

BEFORE
BEFORE
AFTER
AFTER

Unretouched photos of paid JUVÉDERM® XC injectable gel patient. One syringe = 1.0 mL of JUVÉDERM® XC. These photos are not of a clinical trial subject. In clinical trials, optimal correction was achieved with 3.2 mL. Results lasted up to 1 year.

WARNING:

  • Do not inject into blood vessels. Introduction of these products into the vasculature may lead to embolization, occlusion of the vessels, ischemia, or infarction. Take extra care when injecting soft-tissue fillers; for example, inject the product slowly and apply the least amount of pressure necessary. Rare, but serious, adverse events associated with the intravascular injection of soft-tissue fillers in the face have been reported and include temporary or permanent vision impairment, blindness, cerebral ischemia or cerebral hemorrhage leading to stroke, skin necrosis, and damage to underlying facial structures. Immediately stop the injection if a patient exhibits any of the following symptoms: changes in vision, signs of a stroke, blanching of the skin, unusual pain during or shortly after the procedure. Patients should receive prompt medical attention and, possibly, evaluation by an appropriate healthcare professional specialist should an intravascular injection occur
  • Product use at specific sites in which an active inflammatory process (skin eruptions such as cysts, pimples, rashes, or hives) or infection is present should be deferred until the underlying process has been controlled 

Voluma xc®

BEFORE
BEFORE
AFTER (1 MONTH)
AFTER (1 MONTH)
BEFORE
BEFORE
AFTER (1 MONTH)
AFTER (1 MONTH)

Unretouched photos of paid model taken 1 month after treatment. A total of 4.0 mL of JUVÉDERM VOLUMA® XC was injected into the zygomatic arch, anteromedial cheek, and submalar region.

In the clinical trial, the total volume injected ranged from 1.2 mL to 13.9 mL, with a median of 6.6 mL, to achieve optimal correction for all 3 subregions.

BEFORE
BEFORE
AFTER (1 MONTH)
AFTER (1 MONTH)
BEFORE
BEFORE
AFTER (1 MONTH)
AFTER (1 MONTH)

Unretouched photos of paid model taken 1 month after treatment. A total of 3.0 mL of JUVÉDERM VOLUMA® XC was injected into the zygomatic arch, anteromedial cheek, and submalar region.

In the clinical trial, the total volume injected ranged from 1.2 mL to 13.9 mL, with a median of 6.6 mL, to achieve optimal correction for all 3 subregions

BEFORE
BEFORE
AFTER
AFTER

Unretouched photos of paid model taken 1 month after treatment. A total of 3.5 mL of JUVÉDERM VOLUMA® XC was injected into the zygomatic arch, anteromedial cheek, and submalar region. In the clinical trial, the total volume injected ranged from 1.2 mL to 13.9 mL, with a median of 6.6 mL, to achieve optimalcorrection for all 3 subregions.

WARNING:

  • JUVÉDERM VOLUMA® XC injectable gel must not be injected into blood vessels and should not be used in vascular-rich areas. Use in these areas, such as glabella and nose, has resulted in cases of vascular embolization, occlusion of the vessels, ischemia or infarction, or blindness. Symptoms of vessel occlusion and embolization include pain that is disproportionate to the procedure or remote to the injection site, immediate blanching extending beyond the injected area, and color changes that reflect ischemic tissue such as a dusky or reticular appearance
  • Product use at specific sites in which an active inflammatory process (skin eruptions such as cysts, pimples, rashes, or hives) or infection is present should be deferred until the underlying process has been controlled

Bellafill®

BASELINE
BASELINE
AFTER 5 YEARS
AFTER 5 YEARS
BASELINE
BASELINE
AFTER 5 YEARS
AFTER 5 YEARS

Actual Bellafill® patients, individual results may vary.

Actual Bellafill® patients, individual results may vary.

Fraxel® Dual Laser

BROWN SPOTS

BEFORE
BEFORE
AFTER
AFTER
BEFORE
BEFORE
AFTER
AFTER

Tx Settings: 2 Treatments

Tx Settings: 3 Treatments all @ 20mj, 50% coverage, 8 passes

BEFORE
BEFORE
AFTER
AFTER
BEFORE
BEFORE
AFTER
AFTER

Tx Settings: 1 Treatment @ 5mj, 65 % coverage, 8 passes

Tx Settings: 1 Treatment, 10 mj, TL 5, 8 passes, Total kj 1.91

WRINKLE AND ACNE SCARRING

BEFORE
BEFORE
AFTER
AFTER
BEFORE
BEFORE
AFTER
AFTER

Tx Settings: 2 Treatments both @ 70mj

Tx Settings: 5 treatments of Fraxel® 1550

BEFORE
BEFORE
AFTER
AFTER
BEFORE
BEFORE
AFTER
AFTER

Tx Settings: 5 treatments of Fraxel® 1550

Tx Settings: 5 treatments of Fraxel® 1550

BEFORE
BEFORE
AFTER
AFTER

Tx Settings: 6 Treatments of Fraxel® 1550

SKIN REJUVENATION

BEFORE
BEFORE
AFTER
AFTER
BEFORE
BEFORE
AFTER
AFTER

TX Settings: 1 Treatment of Fraxel® DUAL 1550/1927

TX Settings: 3 Treatments with Fraxel® 1550/1927

kybella®

BEFORE
BEFORE
AFTER
AFTER
BEFORE
BEFORE
AFTER
AFTER

Total mLs (all treatment sessions): 12. Individual results may vary.

BEFORE
BEFORE
AFTER
AFTER
BEFORE
BEFORE
AFTER
AFTER

Total mLs (all treatment sessions): 11.0. Individual results may vary.

BEFORE
BEFORE
AFTER
AFTER
BEFORE
BEFORE
AFTER
AFTER

Total mLs (all treatment sessions): 6.8. Individual results may vary.

Acne Scarring

Bellafill for Acne Scars

BEFORE
BEFORE
AFTER
AFTER

FRAXEL 1550

BEFORE
BEFORE
AFTER
AFTER
BEFORE
BEFORE
AFTER
AFTER

Tx Settings: 5 treatments of Fraxel 1550

BEFORE
BEFORE
AFTER
AFTER

Tx Settings: 6 Treatments of Fraxel 1550

SPIDER VEIN Treatment

excel-v_leg-veins3_b

BEFORE

excel-v_leg-veins3_a

AFTER 2 TREATMENTS WITH EXCEL V LASER

excel-v_leg-veins2_b

BEFORE

excel-v_leg-veins2_a

AFTER 2 TREATMENTS WITH EXCEL V LASER

FACIAL REDNESS Treatment

excelv_veins1-b

BEFORE

excelv_veins1-a

AFTER 2 TREATMENTS WITH EXCEL V LASER

excel-v_facial-veins1_b

BEFORE

excel-v_facial-veins1_a

AFTER 2 TREATMENTS WITH EXCEL V LASER

spiderangiomab

BEFORE

spiderangiomaa

AFTER 1 TREATMENT WITH EXCEL V LASER

excel-v_rosacea2_before

BEFORE

excel-v_rosacea2_after

AFTER 1 TREATMENT WITH EXCEL V LASER

Chemical Peels

BEFORE
BEFORE
BEFORE
BEFORE
BEFORE
BEFORE
AFTER 2 PEELS + 6 WEEKS OF LYTERA
AFTER 2 PEELS + 6 WEEKS OF LYTERA

Unretrouched photographs of subject at baseline and after 2 Vitalize Peel procedures in conjunction with basic post-peel skin scar regimen (Facial Cleanser, Ultra Sheer Moisturizer and Daily Physical Defense® Sunscreen Broad Spectrum SPF 30+). Individual results may vary. Data on file at SkinMedica.

Unretrouched photographs taken with standard lighting and baseline and after two Vitalize Peel procedures and six weeks of twice-daily application of LYTERA (registered mark) Skin Brightening Complex in conjunction with basic post-peel skin care regimen (Facial Cleanser, TNS Ceramide Treatment Cream, Ultra Sheer Moisturizer and Daily Physical Defence Sunscreen Broad Spectrum SPF 30+). Individual results may vary. Data on file at SkinMedica.

BEFORE
BEFORE
AFTER 3 PEELS
AFTER 3 PEELS
BEFORE
BEFORE
AFTER 1 MONTH
AFTER 1 MONTH

Unretrouched photographs of subject at baseline and after 3 Rejuvenize® Peel procedures in conjunction with basic post-peel skin scar regimen (Facial Cleanser, Ultra Sheer Moisturizer and Daily Physical Defense® Sunscreen Broad Spectrum SPF 30+). Individual results may vary. Data on file at SkinMedica®.

Unretouched photographs of subjects at baseline and after twice-daily use of TNS Essential Serus®. Individual results may vary. Data on file at SkinMedica®.

BEFORE
BEFORE
AFTER 2 PEELS + 6 WEEKS OF LYTERA
AFTER 2 PEELS + 6 WEEKS OF LYTERA
BEFORE
BEFORE
AFTER 2 MONTHS
AFTER 2 MONTHS

Unretrouched photographs taken with standard lighting and baseline and after two Vitalize Peel® procedures and six weeks of twice-daily application of LYTERA® Skin Brightening Complex in conjunction with basic post-peel skin care regimen (Facial Cleanser, TNS Ceramide Treatment Cream®, Ultra Sheer Moisturizer and Daily Physical Defence® Sunscreen Broad Spectrum SPF 30+). Individual results may vary. Data on file at SkinMedica®.

Clear + Brilliant

BEFORE
BEFORE
1 MONTH POST 6 TREATMENTS
1 MONTH POST 6 TREATMENTS
BEFORE
BEFORE
1 MONTH POST 4 TREATMENTS
1 MONTH POST 4 TREATMENTS
BEFORE
BEFORE
1 MONTH POST 6 TREATMENTS
1 MONTH POST 6 TREATMENTS
BEFORE
BEFORE
1 MONTH POST 6 TREATMENTS
1 MONTH POST 6 TREATMENTS

LASER GENESIS

lg-rednessb

BEFORE

lg-rednessa

AFTER 6 TREATMENTS

lg-acnescarsb

BEFORE

lg-acnescarsa

AFTER 4 TREATMENTS

Schedule an appointment

Offering unique services in each of our 5 locations. Schedule an appointment today!